167
Views
38
CrossRef citations to date
0
Altmetric
Original

Roadmap to a Better Therapeutic Tumor Vaccine

Pages 415-443 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Leisha A Emens. (2012) Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade. Expert Review of Anticancer Therapy 12:12, pages 1597-1611.
Read now
ZhenYu Ding & YuQuan Wei. (2007) Therapeutic vaccine for melanoma: the untouched grail?. Expert Review of Vaccines 6:6, pages 907-911.
Read now
Maurizio Chiriva-Internati, Everardo Cobos & W. Martin Kast. (2007) Advances in Immunotherapy of Multiple Myeloma: From the Discovery of Tumor-Associated Antigens to Clinical Trials. International Reviews of Immunology 26:3-4, pages 197-222.
Read now

Articles from other publishers (35)

Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi & Roddy S. O'Connor. (2023) Current Status and Challenges of Vaccination Therapy for Glioblastoma. Molecular Cancer Therapeutics 22:4, pages 435-446.
Crossref
Cheng-Peng Gui, Jia-Ying Li, Liang-Min Fu, Cheng-Gong Luo, Chi Zhang, Yi-Ming Tang, Li-zhen Zhang, Guan-nan Shu, Rong-Pei Wu & Jun-Hang Luo. (2022) Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer. Journal of Big Data 9:1.
Crossref
Se Hee Park, Kon-Young Ji, Seo Young Park, Hyun Min Kim, Sang Hoon Ma, Ju Hui Do, Hyuno Kang, Hyung Sik Kang, Doo-Byoung Oh, Jae Sung Shim & Young Hee Joung. (2022) Immunotherapeutic effects of recombinant colorectal cancer antigen produced in tomato fruits. Scientific Reports 12:1.
Crossref
Yan Chen, Ning Jiang, Meihua Chen, Baiyan Sui & Xin Liu. (2022) Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development. Frontiers in Cell and Developmental Biology 10.
Crossref
Xin Zhang, Yanlong Zhang, Li Zhao, Jiayu Wang, Jiaxing Li, Xi Wang, Min Zhang & Xiaopeng Hu. (2022) Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer. Frontiers in Immunology 13.
Crossref
Shuhang Wang, Yuqi Yang, Lu Li, Peiwen Ma, Yale Jiang, Minghui Ge, Yue Yu, Huiyao Huang, Yuan Fang, Ning Jiang, Huilei Miao, Hao Guo, Linlin Yan, Yong Ren, Lichao Sun, Yan Zha & Ning Li. (2022) Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development. Vaccines 10:8, pages 1168.
Crossref
Shichao Zhang, Shuqin Li, Ya Wei, Yu Xiong, Qin Liu, Zuquan Hu, Zhu Zeng, Fuzhou Tang & Yan Ouyang. (2022) Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma. Frontiers in Cell and Developmental Biology 10.
Crossref
Zhuohui Chen, Xiang Wang, Zhouyi Yan & Mengqi Zhang. (2022) Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development . Cancer Medicine 11:13, pages 2711-2726.
Crossref
Changwu Wu, Yingjuan Duan, Siming Gong, Georg Osterhoff, Sonja Kallendrusch & Nikolas Schopow. (2022) Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma. Cancers 14:2, pages 448.
Crossref
Xing Huang, Gang Zhang, Tianyu Tang & Tingbo Liang. (2021) Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development. Molecular Cancer 20:1.
Crossref
Shuai Ma, Yixu Ba, Hang Ji, Fang Wang, Jianyang Du & Shaoshan Hu. (2021) Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development. Frontiers in Immunology 12.
Crossref
Hua Zhong, Shuai Liu, Fang Cao, Yi Zhao, Jianguo Zhou, Feng Tang, Zhaohua Peng, Yangsheng Li, Shen Xu, Chunlin Wang, Guohua Yang & Zhi-Qiang Li. (2021) Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine. Frontiers in Immunology 12.
Crossref
Leisha A. Emens. (2016) It’s TIME for a biomarker-driven approach to cancer immunotherapy. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Haiyan Xu, Jie Meng, Qiang Ma & Xiaojin Li. 2016. Biomedical Applications and Toxicology of Carbon Nanomaterials. Biomedical Applications and Toxicology of Carbon Nanomaterials 357 396 .
Guoying Ni, Tianfang Wang, Shelley Walton, Bin Zhu, Shu Chen, Xiaolian Wu, Yuejian Wang, Ming Q. Wei & Xiaosong Liu. (2015) Manipulating IL-10 signalling blockade for better immunotherapy. Cellular Immunology 293:2, pages 126-129.
Crossref
Malaya Bhattacharya-Chatterjee, Sunil K. Chatterjee, Asim Saha & Kenneth A. Foon. 2017. Encyclopedia of Cancer. Encyclopedia of Cancer 771 777 .
Malaya Bhattacharya-Chatterjee, Sunil K. Chatterjee, Asim Saha & Kenneth A. Foon. 2016. Encyclopedia of Cancer. Encyclopedia of Cancer 1 6 .
Eun-Young Lee, Kyong-Su Park, Yae Jin Yoon, Jaewook Lee, Hyung-Geun Moon, Su Chul Jang, Kyoung-Ho Choi, Yoon-Keun Kim & Yong Song Gho. (2012) Therapeutic Effects of Autologous Tumor-Derived Nanovesicles on Melanoma Growth and Metastasis. PLoS ONE 7:3, pages e33330.
Crossref
. 2011. Encyclopedia of Cancer. Encyclopedia of Cancer 630 635 .
Zhao Sun, Wei Wang, Rui Wang, Jinhong Duan, Yan Hu, Jin Ma, Jiayan Zhou, Sishen Xie, Xin Lu, Zhaohui Zhu, Shuchang Chen, Yuanli Zhao, Haiyan Xu, Chen Wang & Xian-Da Yang. (2010) Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine. Cancer Nanotechnology 1:1-6, pages 63-69.
Crossref
HaiYan Xu, Jie Meng & Hua Kong. (2010) What are carbon nanotubes’ roles in anti-tumor therapies?. Science China Chemistry 53:11, pages 2250-2256.
Crossref
Karen Baur, Kay Brinkmann, Marc Schweneker, Juliane Pätzold, Christine Meisinger-Henschel, Judith Hermann, Robin Steigerwald, Paul Chaplin, Mark Suter & Jürgen Hausmann. (2010) Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses. Journal of Virology 84:17, pages 8743-8752.
Crossref
Mladen Korbelik. 2010. Photodynamic Therapy. Photodynamic Therapy 147 153 .
María Teresa Criado, Sandra Sánchez & Carlos M. Ferreirós. (2008) Vacunología clásica y nuevas tecnologías en el diseño de vacunas. Enfermedades Infecciosas y Microbiología Clínica 26:9, pages 564-572.
Crossref
Jie Meng, Jie Meng, Jinhong Duan, Hua Kong, Li Li, Chen Wang, Sishen Xie, Shuchang Chen, Ning Gu, Haiyan Xu & Xian-Da Yang. (2008) Carbon Nanotubes Conjugated to Tumor Lysate Protein Enhance the Efficacy of an Antitumor Immunotherapy. Small 4:9, pages 1364-1370.
Crossref
Qiang Zhou, Xiaocai Yan, Jill Gershan, Rimas J. Orentas & Bryon D. Johnson. (2008) Expression of Macrophage Migration Inhibitory Factor by Neuroblastoma Leads to the Inhibition of Antitumor T Cell Reactivity In Vivo. The Journal of Immunology 181:3, pages 1877-1886.
Crossref
I Heier, P O Hofgaard, P Brandtzæg, F L Jahnsen & M Karlsson. (2008) Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma. Clinical and Experimental Immunology 152:2, pages 381-387.
Crossref
Robert Brodzik, Sergei Spitsin, Max Golovkin, Katarzyna Bandurska, Carla Portocarrero, Monika Okulicz, Zenon Steplewski & Hilary Koprowski. (2007) Plant-derived EpCAM antigen induces protective anti-cancer response. Cancer Immunology, Immunotherapy 57:3, pages 317-323.
Crossref
Taek Joon YoonJi Yeon KimHyojeong KimChangwan HongHyunji LeeChang-Kwon LeeKwang Ho LeeSeokmann HongSe-Ho Park. (2008) Anti-tumor immunostimulatory effect of heat-killed tumor cells. Experimental and Molecular Medicine 40:1, pages 130.
Crossref
W. Nicol Keith & Alan E. Bilsland. 2008. Telomeres and Telomerase in Ageing, Disease, and Cancer. Telomeres and Telomerase in Ageing, Disease, and Cancer 247 283 .
Jürgen Scherer, Thomas Hinz & Klaus Cichutek. (2007) Trends in der Impfstoffentwicklung. DNA‐ und zellbasierte Impfstoffe. Pharmazie in unserer Zeit 37:1, pages 86-92.
Crossref
E. Ovali. (2007) Dendritic cells therapy. ISBT Science Series 2:2, pages 130-134.
Crossref
M Korbelik, B Stott & J Sun. (2007) Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. British Journal of Cancer 97:10, pages 1381-1387.
Crossref
Karl Erik Hellstrom & Ingegerd Hellstrom. (2007) Vaccines to treat cancer‐an old approach whose time has arrived. Journal of Cellular Biochemistry 102:2, pages 291-300.
Crossref
Federica Cavallo, Raffaele Adolfo Calogero & Guido Forni. (2007) Are oncoantigens suitable targets for anti-tumour therapy?. Nature Reviews Cancer 7:9, pages 707-713.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.